R. Kulkarni

发表

Prevalence and risk factors for heart disease among males with hemophilia

B. Evatt, J. Soucie, R. Kulkarni, 2005, American journal of hematology.

Characteristics and Risk Factors of Cancer Associated Venous Thromboembolism.

Ambarina S. Faiz, T. Ortel, J. Heit, 2015, Thrombosis research.

Blood disorders among women: implications for preconception care.

S. Ebrahim, H. Atrash, Christopher S. Parker, 2010, American journal of preventive medicine.

Quality of life in a large multinational haemophilia B cohort (The B‐Natural study) – Unmet needs remain

J. Astermark, C. Kempton, M. Witkop, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Characteristics, complications, and sites of bleeding among infants and toddlers less than 2 years of age with VWD.

C. Thornburg, S. O’Brien, V. Byams, 2021, Blood advances.

Higher rates of bleeding and use of treatment products among young boys compared to girls with von Willebrand disease

S. O’Brien, J. Gill, V. Byams, 2020, American journal of hematology.

A Cross-Sectional Study of Women and Girls with Congenital Bleeding Disorders: The American Thrombosis and Hemostasis Network Cohort.

M. Recht, R. Sidonio, D. Cheng, 2020, Journal of women's health.

Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid

N. Dowling, J. Heit, B. Evatt, 2009, British journal of haematology.

High one year mortality in adults with sickle cell disease and end‐stage renal disease

M. DeBaun, D. Gilbertson, J. Luthi, 2012, British journal of haematology.

The U.S. Thrombosis and Hemostasis Centers pilot sites program

N. Dowling, T. Ortel, J. Heit, 2007, Journal of Thrombosis and Thrombolysis.

Comorbidities, Health-Related Quality of Life, Health-care Utilization in Older Persons with Hemophilia—Hematology Utilization Group Study Part VII (HUGS VII)

M. Nichol, Joanne Wu, B. Konkle, 2022, Journal of blood medicine.

Co-occurrence of Chiari malformations and sickle cell disease-a diagnostic dilemma: a report of 4 cases and review of literature.

R. Kulkarni, S. Chonat, Elna Z. Saah, 2011, Journal of pediatric hematology/oncology.

Disability among individuals with sickle cell disease: literature review from a public health perspective.

S. Grosse, R. Kulkarni, M. Swanson, 2011, American journal of preventive medicine.

National surveillance for hemophilia inhibitors in the United States: Summary report of an expert meeting

D. Aschman, B. Konkle, P. Monahan, 2014, American journal of hematology.

Central venous catheter infections in pediatric patients — in a community hospital

D. Murray, Ashir Kumar, R. Kulkarni, 1988, Infection.

von Willebrand disease Outreach into Integrated Care Education (VOICE): a call to action

M. Wang, B. Konkle, R. Sidonio, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Recombinant factor IX Fc fusion protein in children with haemophilia B (Kids B-LONG): results from a multicentre, non-randomised phase 3 study.

K. Fischer, J. Mahlangu, B. Nolan, 2017, The Lancet. Haematology.

Recombinant factor VIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia A

J. Mahlangu, R. Liesner, B. Nolan, 2015, Journal of thrombosis and haemostasis : JTH.

Clinical causes and treatment of the thrombotic storm

M. Pericak-Vance, J. Vance, T. Ortel, 2012, Expert review of hematology.

Successful treatment of high titer inhibitors in mild hemophilia A with avoidance of factor VIII and immunosuppressive therapy

R. Kulkarni, J. Penner, R. Gera, 2001, American journal of hematology.

Natural history study of factor IX deficiency with focus on treatment and complications (B‐Natural)

J. Astermark, J. Oldenburg, C. Kempton, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

Turoctocog alfa in the treatment of individuals with hemophilia A: review of quality of life data collected in Phase III trials

E. Santagostino, A. Regnault, S. Seremetis, 2015 .

Central venous access device (CVAD) complications in Haemophilia with inhibitors undergoing immune tolerance induction: Lessons from the international immune tolerance study

L. Valentino, D. Warad, V. Rodriguez, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Intracranial and extracranial hemorrhages in newborns with hemophilia: a review of the literature.

J. Lusher, R. Kulkarni, 1999, Journal of pediatric hematology/oncology.

Concerted global effort to combat sickle cell disease: the first global congress on sickle cell disease in Accra, Ghana.

I. Odame, R. Kulkarni, K. Ohene‐Frempong, 2011, American journal of preventive medicine.

Disabilities in adolescents with chronic hematological disorders

R. Kulkarni, Elna Saah, R. Gera, 2008 .

Pediatric transfusion therapy: Practical considerations

R. Kulkarni, R. Gera, 1999, Indian journal of pediatrics.

Differences in thrombotic risk factors in black and white women with adverse pregnancy outcome.

Ambarina S. Faiz, T. Ortel, J. Heit, 2014, Thrombosis research.

Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma‐derived factor concentrates in the era of nucleic acid test screening

C. Kessler, M. Recht, B. Riske, 2013, Transfusion.

The effect of secondary prophylaxis versus episodic treatment on the range of motion of target joints in patients with haemophilia

J. Gill, A. Siddiqi, J. Soucie, 2013, British journal of haematology.

Disabilities in adolescents with cancer

R. Kulkarni, Elna Z. Saah, R. Gera, 2008 .

Characteristics of abdominal vein thrombosis in children and adults

T. Ortel, J. Heit, N. Key, 2013, Thrombosis and Haemostasis.

CDC Division of Blood Disorders: public health research activities in venous thromboembolism.

W. Hooper, Althea M. Grant, M. Beckman, 2008, Arteriosclerosis, thrombosis, and vascular biology.

Intracranial Venous Sinus Thrombosis Complicated by Disseminated Intravascular Coagulation in a Teenager Following Knee Injury

M. Pericak-Vance, J. Vance, T. Ortel, 2011 .

Penicillin-resistant Streptococcus mitis as a cause of septicemia with meningitis in febrile neutropenic children.

D. Murray, R. Kulkarni, R. Gera, 1997, Journal of pediatric hematology/oncology.

Sickle cell disease: current activities, public health implications, and future directions.

M. Creary, D. Williamson, R. Kulkarni, 2007, Journal of women's health.

Screening for von Willebrand disease in children: a case–control study

C. Kempton, P. Kouides, M. Ragni, 2011, Journal of thrombosis and haemostasis : JTH.

The frequency of joint hemorrhages and procedures in nonsevere hemophilia A vs B.

B. Konkle, P. Monahan, J. Soucie, 2018, Blood advances.

Improved joint health in subjects with severe haemophilia A treated prophylactically with recombinant factor VIII Fc fusion protein

J. Dumont, J. Oldenburg, V. Blanchette, 2018, Haemophilia.

Community counts: Evolution of a national surveillance system for bleeding disorders

D. Aschman, M. Recht, V. Byams, 2018, American journal of hematology.

Clinical perspectives of emerging pathogens in bleeding disorders

M. Diamond, P. Simmonds, S. Bozzette, 2006, The Lancet.

Comprehensive care of the patient with haemophilia and inhibitors undergoing surgery: practical aspects

R. Kulkarni, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Associations between intracranial haemorrhage and prescribed prophylaxis in a large cohort of haemophilia patients in the United States

C. Manno, C. Witmer, J. Soucie, 2011, British journal of haematology.

Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factors.

Roshni Kulkarni, Keith Hoots, Heather Huszti, 2004, Blood.

Therapeutic choices for patients with hemophilia and high‐titer inhibitors

M. Poon, L. Aledort, E. Berntorp, 2001, American journal of hematology.

Reliability of patient-reported outcome instruments in US adults with hemophilia: the Pain, Functional Impairment and Quality of life (P-FiQ) study

T. Buckner, Michael Wang, D. Cooper, 2017, Patient preference and adherence.

Turoctocog alfa and drug development for hemophilia A

J. Staber, S. Seremetis, S. Lentz, 2014 .

Long-term safety and efficacy of extended-interval prophylaxis with recombinant factor IX Fc fusion protein (rFIXFc) in subjects with haemophilia B.

J. Oldenburg, D. Perry, M. Ozelo, 2016, Thrombosis and haemostasis.

Long-term safety and efficacy of extended-interval prophylaxis with recombinant factor IX Fc fusion protein ( rFIXFc ) in subjects with haemophilia

J. Oldenburg, D. Perry, M. Ozelo, 2017 .

Results from a large multinational clinical trial (guardian™3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokinetics

E. Santagostino, M. Ozelo, V. Vdovin, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Favorable pharmacokinetics in hemophilia B for nonacog beta pegol versus recombinant factor IX‐Fc fusion protein: A randomized trial

R. Klamroth, M. Simpson, C. Escuriola Ettingshausen, 2019, Research and practice in thrombosis and haemostasis.

Population Pharmacokinetic Modeling Of On-Demand And Surgical Use Of Nonacog Beta Pegol (N9-GP) And rFIXFc Based Upon The paradigm 7 Comparative Pharmacokinetic Study

D. Cooper, R. Klamroth, M. Simpson, 2019, Journal of blood medicine.

Recombinant factor VIII Fc fusion protein: extended‐interval dosing maintains low bleeding rates and correlates with von Willebrand factor levels

J. Dumont, I. Nestorov, D. Quon, 2014, Journal of thrombosis and haemostasis : JTH.

Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.

J. Dumont, I. Nestorov, D. Perry, 2014, Blood.

Use of telehealth in the delivery of comprehensive care for patients with haemophilia and other inherited bleeding disorders

R. Kulkarni, R. Kulkarni, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A.

D. Quon, J. Staber, B. Konkle, 2020, The New England journal of medicine.

Long‐term safety and sustained efficacy for up to 5 years of treatment with recombinant factor IX Fc fusion protein in subjects with haemophilia B: Results from the B‐YOND extension study

J. Oldenburg, M. Ozelo, H. Chambost, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

Post hoc analysis to evaluate the effect of recombinant factor IX Fc fusion protein (rFIXFc) prophylaxis in adults and adolescents with target joints and hemophilia B

K. Pasi, R. Liesner, N. Jain, 2016 .

Perinatal management of newborns with haemophilia

J. Lusher, R. Kulkarni, 2001, British journal of haematology.

Global Emerging HEmophilia Panel (GEHEP): A Multinational Collaboration for Advancing Hemophilia Research and Treatment

J. Mahlangu, M. Mancuso, R. Kruse-Jarres, 2013, Transfusion Medicine and Hemotherapy.

Renal disease among males with haemophilia

B. Evatt, J. Soucie, R. Kulkarni, 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

Models of Comprehensive Multidisciplinary Care for Individuals in the United States With Genetic Disorders

S. Grosse, B. Strickland, E. Trevathan, 2009, Pediatrics.

Alternative and topical approaches to treating the massively bleeding patient.

R. Kulkarni, 2004, Clinical advances in hematology & oncology : H&O.

Successful use of activated recombinant factor VII in traumatic liver injuries in children.

J. Fath, R. Kulkarni, S. Guertin, 2004, The Journal of trauma.

Serologic markers of viral hepatitis A, B, C, and D in patients with hemophilia

D. Murray, Ashir Kumar, R. Kulkarni, 1993, Journal of Medical Virology.

More on: are randomized clinical trials the only truth? Not always

P. Mannucci, C. Kessler, P. Monahan, 2006, Journal of thrombosis and haemostasis : JTH.

hemophilia A Phase 3 study of recombinant factor VIII Fc fusion protein in severe

J. Dumont, I. Nestorov, D. Perry, 2014 .

Unresolved issues in diagnosis and management of inherited bleeding disorders in the perinatal period: A White Paper of the Perinatal Task Force of the Medical and Scientific Advisory Council of the National Hemophilia Foundation, USA

K. Ponder, J. Soucie, W. Hoots, 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

Pediatric Hemophilia: A Review

J. Soucie, R. Kulkarni, Roshni Kulkarni1, 2011, Seminars in thrombosis and hemostasis.

Inhibitors in haemophilia A: a perspective on clotting factor products as a potential contributing factor

T. Humphries, H. Dinter, N. Church, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Extending recombinant factor IX Fc fusion protein dosing interval to 14 or more days in patients with hemophilia B

M. Ozelo, S. Lethagen, K. Pasi, 2018, Research and practice in thrombosis and haemostasis.

Challenges in the management of haemophilia on transition from adolescence to adulthood

B. Brand, R. Kulkarni, Spencer Dunn, 2015, European journal of haematology.

A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH

M. Othman, J. Mahlangu, P. James, 2021, Journal of thrombosis and haemostasis : JTH.

Women and girls with haemophilia and bleeding tendencies: Outcomes related to menstruation, pregnancy, surgery and other bleeding episodes from a retrospective chart review

R. Sidonio, N. Jain, R. Kulkarni, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

Why plasma‐derived factor VIII?

C. Leissinger, M. Recht, G. Young, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

Safety, Efficacy, and Pharmacokinetics of Recombinant Factor VIII FC Fusion Protein (RFVIIIFC) in Previously Treated Paediatric Subjects with Severe Haemophilia A (Kids A-LONG)

J. Mahlangu, B. Nolan, G. Young, 2013 .

Low bleeding rates with increase or maintenance of physical activity in patients treated with recombinant factor VIII Fc fusion protein (rFVIIIFc) in the A‐LONG and Kids A‐LONG Studies

B. Kerlin, D. Quon, G. Castaman, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Low Bleeding Rates with Increase or Maintenance of Physical Activity in Patients Treated with Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in the A-LONG and Kids A-LONG Studies

B. Kerlin, D. Quon, G. Castaman, 2015 .

Safety, Efficacy, and Pharmacokinetics of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously-Treated Children with Severe Hemophilia a (Kids-ALONG)

J. Mahlangu, B. Nolan, G. Young, 2014 .

Improving care and treatment options for women and girls with bleeding disorders

R. Kulkarni, 2015, European journal of haematology.

Efficacy, safety and pharmacokinetics of a new high‐purity factor X concentrate in women and girls with hereditary factor X deficiency

A. James, A. Shapiro, R. Kulkarni, 2018, Journal of thrombosis and haemostasis : JTH.

B-YOND Final Results Confirm Established Safety, Sustained Efficacy, and Extended Dosing Interval for Up to 4 Years of Treatment With rFIXFc in Previously Treated Subjects With Severe Hemophilia B

J. Oldenburg, K. Pasi, K. Fischer, 2018, Blood.

Intracranial Hemorrhage in Patients with Hemophilia in the Prophylaxis Era.

C. Manno, C. Witmer, J. Soucie, 2008 .

The Coags Uncomplicated App: Fulfilling Educational Gaps Around Diagnosis and Laboratory Testing of Coagulation Disorders

D. Cooper, C. Kessler, E. Peerschke, 2017, JMIR medical education.

Quality of Life in Female Adolescents with Bleeding Disorders

R. Kulkarni, A. Pawar, Anjali Pawar, 2020 .

The spectrum and severity of bleeding in adolescents with low von Willebrand factor-associated heavy menstrual bleeding.

S. O’Brien, C. Minard, P. Kouides, 2020, Blood advances.

Evaluation of a screening tool for bleeding disorders in a US multisite cohort of women with menorrhagia.

Ambarina S. Faiz, J. Heit, P. Kouides, 2011, American journal of obstetrics and gynecology.

The spectrum of haemostatic characteristics of women with unexplained menorrhagia

N. Dowling, J. Heit, P. Kouides, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Validation Study of the Composite Score to Identify Von Willebrand Disease in Children

C. Moore, B. Kerlin, C. Witmer, 2013, Journal of pediatric hematology/oncology.

IGIV-C, a novel intravenous immunoglobulin: evaluation of safety, efficacy, mechanisms of action, and impact on quality of life

A. Angiolillo, J. Kelton, J. Bussel, 2004, Thrombosis and Haemostasis.

Treatment of Severe Pulmonary Hemorrhage With Activated Recombinant Factor VII (rFVIIa) in Very Low Birth Weight Infants

N. Olomu, M. Manco‐Johnson, R. Kulkarni, 2002, Journal of Perinatology.

Differences in bleeding phenotype and provider interventions in postmenarchal adolescents when compared to adult women with bleeding disorders and heavy menstrual bleeding

P. Kouides, A. James, V. Byams, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Perceptions about quality of life in a school‐based population of adolescents with menorrhagia: implications for adolescents with bleeding disorders

R. Kulkarni, K. Davis, K. Bosma, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children.

S. Bertolone, G. Young, M. Tarantino, 2006, The Journal of pediatrics.

A closer look at intravascular hemolysis (IVH) following intravenous anti-D for immune thrombocytopenic purpura (ITP).

J. Bussel, D. Cines, E. Grabowski, 2007, Blood.

Evidence for the continued transmission of parvovirus B19 in patients with bleeding disorders treated with plasma‐derived factor concentrates

C. Kessler, M. Recht, B. Riske, 2013, Transfusion.

Neonatal Hemostatic Disorders: Issues and Challenges

M. Chitlur, R. Kulkarni, R. Jesudas, 2016, Seminars in Thrombosis and Hemostasis.

Nondisclosure of Human Immunodeficiency Virus and Hepatitis C Virus Coinfection in a Patient With Hemophilia: Medical and Ethical Considerations

H. Brody, M. Ragni, R. Kulkarni, 2001, Journal of pediatric hematology/oncology.

Thrombotic storm revisited: preliminary diagnostic criteria suggested by the thrombotic storm study group.

M. Pericak-Vance, J. Vance, T. Ortel, 2011, The American journal of medicine.

Astroblastoma: Does histology predict biologic behavior?

M. Rosenblum, J. Finlay, B. Thiessen, 1998, Journal of Neuro-Oncology.

Severe intrarenal fibrosis, infundibular stenosis, renal cysts, and persistent perilobar nephrogenic rests in a patient with Beckwith-Wiedemann syndrome 27 years after diffuse nephroblastomatosis and Wilms tumor: natural progression or a consequence of treatment?

J. Wolf, R. Kulkarni, N. Padiyar, 2002, Journal of pediatric hematology/oncology.

Erratum: Therapeutic choices for patients with hemophilia and high-titer inhibitors (American Journal of Hematology (2001) 67 (240-246))

M. Poon, L. Aledort, E. Berntorp, 2002 .

Variants in chondroitin sulfate metabolism genes in thrombotic storm.

M. Pericak-Vance, J. Vance, T. Ortel, 2018, Thrombosis research.

Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities in health services; diversity, equity, and inclusion; and implementation science

A. Dinno, T. Buckner, V. Byams, 2023, Expert review of hematology.

Comparison of characteristics from White‐ and Black‐Americans with venous thromboembolism: A cross‐sectional study

T. Ortel, J. Heit, N. Key, 2010, American journal of hematology.

State of Telehealth.

R. Malouin, R. Kulkarni, 2016, The New England journal of medicine.

A community-based partnership to promote information infrastructure for bleeding disorders.

D. Aschman, A. Forsberg, A. Shapiro, 2011, American journal of preventive medicine.

Whole-exome analysis of adolescents with low VWF and heavy menstrual bleeding identifies novel genetic associations

S. O’Brien, J. Di Paola, C. Minard, 2021, Blood advances.

Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research to advance the health of people with inherited bleeding disorders with the potential to menstruate

C. Philipp, S. Ragosta, R. Kulkarni, 2023, Expert review of hematology.

Multicenter dose‐finding and efficacy and safety outcomes in neonates and children treated with dalteparin for acute venous thromboembolism

S. O’Brien, S. Burr, N. Goldenberg, 2014, Journal of thrombosis and haemostasis : JTH.

Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A.

J. Oldenburg, V. Jiménez‐Yuste, B. Konkle, 2023, The New England journal of medicine.

First study of extended half-life rFVIIIFc in previously untreated patients with hemophilia A: PUPs A-LONG final results

C. Königs, M. Ozelo, M. Carcao, 2022, Blood.

Sickle Cell Disease Summit: From clinical and research disparity to action

B. Pace, W. Woods, J. Eckman, 2009, American journal of hematology.

Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment Centres

B. Konkle, J. Gill, P. Kouides, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Efanesoctocog Alfa Half-Life and Clearance Are Independent of von Willebrand Factor in Severe Hemophilia A: A Post Hoc Analysis from Phase 1/2a Studies

J. Dumont, D. Quon, J. Staber, 2021, Blood.

Depression and anxiety in persons with Von Willebrand disease

M. Nichol, Joanne Wu, B. Konkle, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial.

Kenneth J. Smith, D. Bellissimo, E. Kraut, 2023, The Lancet. Haematology.

Transient acute renal failure (ARF) and anti-D intravascular hemolysis (IVH) following intravenous (IV) treatment of immune thrombocytopenia (ITP)

R. Kulkarni, R. Gera, A. Scott-Emuakpor, 2000 .

Long-Term Efficacy and Quality of Life with Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) Prophylaxis in Pediatric, Adolescent, and Adult Subjects with Target Joints and Severe Hemophilia a

B. Kerlin, Michael Wang, S. Lethagen, 2016 .

Predictors of Von Willebrand Disease In Children: A Case-Control Study

C. Kempton, P. Kouides, M. Ragni, 2010 .

Venous Thromboembolism (VTE) Characteristics among White- and Black-Americans: a Cross Sectional Study

T. Ortel, J. Heit, N. Key, 2008 .

Evaluation of a screening tool for bleeding disorders in a US multisite cohort of women with menorrhagia.

Ambarina S. Faiz, J. Heit, P. Kouides, 2011, American journal of obstetrics and gynecology.

Improving care and treatment options for women and girls with bleeding disorders

R. Kulkarni, 2015, European journal of haematology.

Prophylaxis with a recombinant factor VIII Fc in hemophilia A: long-term follow-up on joint health, efficacy, and safety from phase 3 studies in children and adults

V. Blanchette, C. Négrier, S. Lethagen, 2023, Research and practice in thrombosis and haemostasis.

Depression and anxiety in persons with Von Willebrand disease

M. Nichol, Joanne Wu, B. Konkle, 2022, Haemophilia.

Healthcare Utilization and Health Related Quality of Life in Persons with Von Willebrand Disease

M. Nichol, Joanne Wu, B. Konkle, 2020 .

Disability among individuals with sickle cell disease: literature review from a public health perspective.

S. Grosse, R. Kulkarni, M. Swanson, 2011, American journal of preventive medicine.

A Multi-Site, Prospective Cross-Over Study of Intranasal Desmopressin and Oral Tranexamic Acid in Women with Menorrhagia and Abnormal Laboratory Hemostasis.

J. Heit, B. Evatt, P. Kouides, 2007 .

A Retrospective Analysis of the American Thrombosis and Hemostasis Network Dataset Describing Outcomes of Dental Extractions in Persons with Hemophilia

M. Recht, Chunla He, R. Kulkarni, 2023, Journal of clinical medicine.

Genotypic and Phenotypic Analysis of Adolescents with Heavy Menstrual Bleeding and Low Von Willebrand Activity - Interim Report of a Multi-Center Study

S. O’Brien, C. Minard, P. Kouides, 2018, Blood.